FrankfurtThe medicine company Fresenius has insiders according to potential interested parties for its blood transfusion business addressed. Fresenius has appointed investment bank Goldman Sachs as an advisor for a potential sale, two people familiar with the plan told Reuters on Friday. Fresenius and Goldman Sachs did not want to comment on the information. First, the "Frankfurter Allgemeine Zeitung" reported on the project.
Transfusion (t) Transfusion (t) Medicine (m) Mergers & Acquisitions M & A (t) Brokers (t) Investment Funds (t) Investment (t) Investment Fraud (t) Media (t) Press (t) Business Succession (t) Pharmaceutical Industry (t) Banking & Financial Institutions (t) Medical Services (t) Business Consulting (t) Hospitals (t) Securities Traders (t) Medical Technology